ACYTE Biotech and Xell AG announce strategic partnership and launch AXYTE product and services portfolio

18 Jan 2016

ACYTE Biotech and Xell AG today announced the two companies will combine their capabilities to launch a new product and service portfolio under the brand AXYTE. AXYTE represents the synergy of tailored cell line generation, cell culture media and process development. Please see press release here. For further information please contact Dr Aoife Cullen, aoife@acyte.com.au.

Back to news

News